Chitosan in Modern Pharmacotherapy: From Drug Encapsulation to Targeted Delivery Systems

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: 10 December 2025 | Viewed by 40

Special Issue Editors


E-Mail Website
Guest Editor
Institute of Physiology and Pharmacology, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
Interests: chitosan-based nanoparticles; oxidative stress; targeted drug delivery; biopharmaceutical applications; clinical translation

E-Mail Website
Guest Editor
Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania
Interests: chitosan-based nanoparticles; oxidative stress; targeted drug delivery; biopharmaceutical applications; clinical translation

E-Mail Website
Guest Editor
Department of Biochemistry, Medical Academy, Lithuanian University of Health Sciences, Eiveniu str. 4, Kaunas, Lithuania
Interests: chitosan-based nanoparticles; oxidative stress; targeted drug delivery; biopharmaceutical applications; clinical translation

E-Mail Website
Guest Editor
Department of Biochemistry, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, Eiveniu str. 4, LT-50009 Kaunas, Lithuania
Interests: chitosan-based nanoparticles; oxidative stress; targeted drug delivery; biopharmaceutical applications; clinical translation

Special Issue Information

Dear Colleagues,

Chitosan, a natural, biodegradable, and biocompatible polysaccharide, has emerged as a promising material for advanced drug delivery systems due to its excellent mucoadhesive properties, ease of chemical modification, and ability to respond to physiological stimuli. Recent research highlights its potential in targeted and controlled drug delivery, especially for combating oxidative stress-related diseases, where redox-sensitive systems can greatly improve therapeutic outcomes. This Special Issue aims to gather innovative studies and reviews that explore the pharmacological benefits, formulation strategies, and clinical applications of chitosan-based drug carriers. We especially welcome manuscripts focusing on nano- and micro-structured systems, injectable hydrogels, mucosal delivery platforms, and chitosan derivatives with enhanced solubility and stability. Contributions bridging the gap between experimental results and clinical implementation are encouraged.

We look forward to receiving your submissions.

Dr. Robertas Lazauskas
Prof. Dr. Dalia Adukauskienė
Dr. Lolita Kuršvietienė
Dr. Inga Staneviciene
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • chitosan-based nanoparticles
  • oxidative stress
  • targeted drug delivery
  • biopharmaceutical applications
  • clinical translation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop